Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

被引:414
作者
Mow, WS
Vasiliauskas, EA
Lin, YC
Fleshner, PR
Papadakis, KA
Taylor, KD
Landers, CJ
Abreu-Martin, MT
Rotter, JI
Yang, HY
Targan, SR
机构
[1] Div Gastroenterol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA
[3] Steven Spielberg Pediat Res Ctr, Dept Pediat, Ctr Med Genet Birth Defects, Los Angeles, CA USA
关键词
D O I
10.1053/j.gastro.2003.11.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Crohn's disease patients can be characterized by antibody responses against Crohn's disease-related bacterial sequence, Escherichia coli outer membrane porin C, Saccharomyces cerevisiae (oilgomannan), and neutrophil nuclear antigens. Our aim was to determine whether expression of antibodies against Crohn's disease-related bacterial sequence and Escherichia coli outer membrane porin C is associated with distinct phenotypic manifestations. Methods: Sera from 303 patients were tested for antibodies to the Crohn's disease-related bacterial sequence (12), anti-Escherichia coli outer membrane porin C, anti-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibodies and for 3 Crohn's disease-associated variants of the NOD2 gene (R702W, G908R, and 1007fs) and compared with clinical data. Results: Patients expressing 12 were more likely to have fibrostenosing Crohn's disease (64.4% vs. 40.7%; P < 0.001) and to require small bowel surgery (62.2% vs. 37.4%; P < 0.001). Patients with anti-Escherichia coli outer membrane porin C were more likely to have internal perforating disease (50.0% vs. 30.7%; P = 0.001) and to require small bowel surgery (61.4% vs. 44.2%; P = 0.003). Anti-Crohn's disease-related bacterial sequence was independently associated with fibrostenosis (P = 0.027) and small bowel surgery (P = 0.01), whereas anti-Escherichia coli outer membrane porin C was independently associated with internal perforations (P < 0.006). Patients positive for 12, anti-Escherichia coli outer membrane porin C, and anti-Saccharomyces cerevisiae were the most likely to have undergone small bowel surgery (72.0%; odds ratio, 8.6; P < 0.001) compared with patients without reactivity (23.0%). When the presence and magnitude of antibody responses were considered, 90% of patients with small bowel disease who required surgery had high levels of 12, Escherichia coli outer membrane porin C, and oligomannan antibodies, compared with only 18.2% with low-titer responses (P < 0.001). Conclusions: 12 and anti-Escherichia coli outer membrane porin C are associated with Crohn's disease phenotypes, and patients with the highest level of serum reactivity toward an increasing number of microbiota have the greatest frequency of strictures, internal perforations, and small bowel surgery.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 43 条
[21]   Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens [J].
Landers, CJ ;
Cohavy, O ;
Misra, R ;
Yang, HY ;
Lin, YC ;
Braun, J ;
Targan, SR .
GASTROENTEROLOGY, 2002, 123 (03) :689-699
[22]   Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study [J].
Lavy, A ;
Broide, E ;
Reif, S ;
Keter, D ;
Niv, Y ;
Odes, S ;
Eliakim, R ;
Halak, A ;
Ron, Y ;
Patz, J ;
Fich, A ;
Villa, Y ;
Arber, N ;
Gilat, T .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (06) :472-476
[23]   CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease [J].
Lesage, S ;
Zouali, H ;
Cézard, JP ;
Colombel, JF ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, C ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Modigliani, R ;
Gower-Rousseau, C ;
Macry, J ;
Merlin, F ;
Chamaillard, M ;
Jannot, AS ;
Thomas, G ;
Hugot, JP .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (04) :845-857
[24]   IMMUNOCYTOCHEMICAL EVIDENCE OF LISTERIA, ESCHERICHIA-COLI, AND STREPTOCOCCUS ANTIGENS IN CROHNS-DISEASE [J].
LIU, Y ;
VANKRUININGEN, HJ ;
WEST, AB ;
CARTUN, RW ;
CORTOT, A ;
COLOMBEL, JF .
GASTROENTEROLOGY, 1995, 108 (05) :1396-1404
[25]   Allelic discrimination using fluorogenic probes and the 5′ nuclease assay [J].
Livak, KJ .
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING, 1999, 14 (5-6) :143-149
[26]   Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype [J].
Louis, E ;
Michel, V ;
Hugot, JP ;
Reenaers, C ;
Fontaine, F ;
Delforge, M ;
El Yafi, F ;
Colombel, JF ;
Belaiche, J .
GUT, 2003, 52 (04) :552-557
[27]   Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease [J].
Louis, E ;
Collard, A ;
Oger, AF ;
Degroote, E ;
El Yafi, FAN ;
Belaiche, J .
GUT, 2001, 49 (06) :777-782
[28]   A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease [J].
Ogura, Y ;
Bonen, DK ;
Inohara, N ;
Nicolae, DL ;
Chen, FF ;
Ramos, R ;
Britton, H ;
Moran, T ;
Karaliuskas, R ;
Duerr, RH ;
Achkar, JP ;
Brant, SR ;
Bayless, TM ;
Kirschner, BS ;
Hanauer, SB ;
Nuñez, G ;
Cho, JH .
NATURE, 2001, 411 (6837) :603-606
[29]  
Pardi DS, 2000, AM J GASTROENTEROL, V95, P1480, DOI 10.1111/j.1572-0241.2000.02082.x
[30]  
PRANTERA C, 1994, AM J GASTROENTEROL, V89, P513